The immune health supplements market size in Europe was valued at USD 14.13 billion in 2023. The European market size is predicted to progress at a CAGR of 6.2% from 2024 to 2032 and be worth USD 24.28 billion by 2032 from USD 15.01 billion in 2024.
In recent years, the changing lifestyle of people, increasing urbanization, and increasing health consciousness among people have supported the call for supplements. The rapidly growing aged group population with a prevalence of chronic diseases is expected to create market opportunities for immune health supplements in the European region. Due to a lack of immunity, humans are suffering from various diseases. This is the reason why senior citizens are more prone to chronic disorders, loss of hunger and weak immune system of the body. Such a condition requires supplements enriched with an additional dietary supplement that is popular mostly among all ages of the population.
The rising consciousness for health and nutrition among consumers and increasing willingness to spend on dietary supplements are promoting the expansion of the European market. Increasing lifestyle diseases and growing immune health concerns among baby boomers are some of the factors that boost the growth of the European immune health supplements market. The baby boomer population is increasing at a faster rate in the European nations, leading to a rising health concern. To deal with this situation, manufacturers are in the process of developing innovative health supplements that can be found in large-scale forms like liquid and powder in order to strengthen the immune system of humans. The demand in the old age population is likely to fuel the European immune health supplement market in the years to come.
A challenge is that “immune health supplement” health products are often very emotive and polarizing topics, evoking a diverse range of opinions and viewpoints. Lack of awareness about immune health supplements among consumers is anticipated to hamper the regional immune health supplements market growth.
Among these, the vitamin segment is expected to gain the highest share in the coming years due to the antioxidant feature of vitamins that help the body fight against infections, along with supporting biochemical reactions in the immune system. This segment accounts for a high revenue share in the European immune health supplements market and is determined to record a substantial growth rate over the forecast period.
By form, the soft gels/pills segment is expected to show a high market attractiveness index over the projection period in the immune health supplementary market.
The adult segment forms the largest consumer group in the market, accounting for 39.8% of the total revenue in 2016. There is a significant prevalence of various lifestyle disorders in this age group, such as high blood pressure, diabetes, and obesity, owing to which they need supplements. In addition, increasing the purchasing power of adult consumers in European countries such as the UK, Germany, Italy, France, Spain, and Russia is projected to fuel market growth.
As of 2023, Italy, Germany and France were among the key markets with approximately 30% share. Spain and the U.K. have shown considerable growth with a large number of products launches in the past few years. The market in Europe is estimated to progress with the changing dynamics as it moves toward consolidation, which is balanced by several mergers and acquisitions.
Alticor Inc (Amway), EuroPharma Inc, Nutramax Laboratory, General nutrition centers, Pfizer, Abbott, Bayer AG, Sanofi, and LivaNova PLC, are a few of the notable companies in the Europe immune health supplements market.
This research report on the European immune health supplements market is segmented and sub-segmented into the following categories.
By ingredient type
By Forms
By Sales Channels
By Age Group
By Country
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region